Love Pharma’s funding in US biotech delivers strategic business advantages and enhanced shareholder worth

Love Pharma Inc. (CSE: LUV) (FSE: G1Q0), a world psychological well being and sexual well being firm, is extraordinarily energetic in shaping itself into an actual competitor within the biotechpharmaceutical house. The corporate’s progress and improvement plan took a serious leap ahead this week with the announcement that Love Pharma is forging a “strategic alliance” … Read more